reilly: "Don't even bother responding."
Good advice. I'll go one better. Put him on "ignore" for his ridiculous comments.
I'm doing it right after I submit this post.
I seriously doubt if it will take another 2 years since they are going commercial in a few months, cjg. Glad your making some nice money now. All longs will over the course of the next 6 months to a year and going forward.
While the shorts lay eggs...
That pretty well sums it up.
"lessen" (not "lesson")
Geez! As you can tell, I didn't proof the original before submitting it. Sorry.
Yes. I agree. Additional stock offering = dilution.
That said, Keith did say it would be to raise funds for a quicker turnaround of research opportunities. He said they had $5M cash on hand as of 6/30/14, I believe. And they would like to double that to hurry up those opps. $45M would be roughly 6M addl shares at current mkt value which translate into 7.5% dilution. He further indicated that they would consider a secondary offering to institutional investors to lesson the overall dilution.
So, while I was at first rather disappointed in this, it does seem that this addl cash infusion will lead to faster rollouts of the liver, kidney, skin/eye, etc. research/commercialization effort with minimum effect on shareholder equity. If this is what ONVO sees as the necessary, next-step to proceed, then I'm for it.
There are too many questions/warnings about this drug. I see a very small market for it. Small market = low revenue.
That's why the big money is selling or staying away. Simple as that.
Actually I sold a little earlier. I have to purchase a canoe...
A little profit taking now after the run up yesterday, no doubt.
Murphy and company at 12:15 today. That should get it going again.
"The effect of Contrave on cardiovascular morbidity and mortality has not been established. In addition, the safety and effectiveness of Contrave in combination with other medications intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.
The exact neurochemical effects of Contrave leading to weight loss are not fully understood."
And yet the FDA approved it? Great job FDA...
Ah, good. You got it, juggsy. I tried to copy the same passage, but couldn't for some reason.
Also, I was glad to see that the individual holdings of the directors increased from a year ago. They are invested in the company.